D. A. Bakker, M. Fitch, R. Gray, E. Reed, and J. Bennett, Patient-health care provider communication during chemotherapy treatment: the perspectives of women with breast cancer, Patient Education and Counseling, vol.43, pp.61-71, 2001.

P. Bourret, F. Eisinger, and J. P. Moatti, Chimioprévention médicalisée des cancers. Un point de vue des sciences sociales, Bulletin du Cancer, vol.82, pp.224-229, 1995.

G. Bronner, L'empire de l'erreur. Éléments de sociologie cognitive, 2007.
URL : https://hal.archives-ouvertes.fr/halshs-00271674

P. Cannone, L. Dany, E. Dudoit, F. Duffaud, S. Salas et al., Étude des représentations sociales de la chimiothérapie : une voie d'analyse des relations entre patients et médecins oncologues, Bulletin du Cancer, vol.91, pp.279-84, 2004.

P. Castel, La gestion de l'incertitude médicale : approche collective et contrôle latéral en cancérologie, Sciences Sociales et Santé, vol.26, pp.9-31, 2008.

C. Chao, J. L. Studts, T. Hadley, L. Roetzer, S. Dineen et al., Adjuvant chemotherapy for breast cancer: how presentation of recurrence risk influences decision-making, Journal of Clinical Oncology, vol.21, pp.4299-4305, 2003.

C. Charles, C. Redko, T. Whelan, A. Gafni, and L. Reyno, Doing nothing is not a choice: lay constructions of treatment decision-making among women with early-stage breast cancer, Sociology of Health and Illness, vol.20, pp.71-95, 1998.

R. Clarke, F. Leonessa, J. N. Welch, and T. C. Skaar, Celular and molecular pharmacology of antioestrogen action and resistance, Pharmacological Reviews, vol.53, pp.25-71, 2001.

P. Conrad, The meaning of medications: another look at compliance, Social Science and Medicine, vol.20, pp.29-37, 1985.

D. Delanoë, P. Sexe, and H. Littérature, , 2006.

D. Good, M. J. Munakata, T. Kobayashi, Y. Mattingly, C. Good et al., Oncology and narrative time, Social Science and Medicine, vol.38, pp.855-862, 1994.

D. Good and M. J. , Cultural studies of biomedicine: an agenda for research, Social Science and Medicine, vol.41, pp.461-473, 1995.

A. Desclaux and J. J. Lévy, Culture et médicaments. Ancien objet ou nouveau courant en anthropologie médicale ?, vol.27, pp.5-21, 2003.

, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials, The Lancet, vol.365, pp.1687-717, 2005.

L. Elit, C. Charles, I. Gold, A. Gafni, S. Farell et al., Women's perceptions about treatment decision making for ovarian cancer, Gynecologic Oncology, vol.88, pp.89-95, 2003.

S. Fainzang, La relation médecins-malades : information et mensonge, 2006.

S. Ford, L. Fallowfield, and S. Lewis, Doctor-patient interactions in oncology, Social Science and Medicine, vol.11, pp.1511-1519, 1996.

J. Fosket, Constructing "high-risk women": the development and standardization of a breast cancer risk assessment tool, Technology, & Human Values, vol.29, pp.291-313, 2004.

E. Friedson, La profession médicale, 1970.

B. G. Glaser and A. Strauss, La découverte de la théorie ancrée. Stratégies pour la recherche qualitative, 1967.

M. Lock, Breast cancer: reading the omens, Anthropology Today, vol.14, pp.7-16, 1998.

C. L. Loprinzi and T. S. , Understanding the utility of adjuvant systemic therapy for primary breast cancer, Journal of Clinical Oncology, vol.19, pp.972-979, 2001.

I. Löwy and J. P. Gaudillière, Médicalisation de la ménopause, mouvements pour la santé des femmes et controverses sur les thérapies hormonales, Nouvelles Questions Féminines, vol.25, pp.48-65, 2006.

R. Massé, Les mirages de la rationalité des savoirs ethnomédicaux, vol.21, pp.53-72, 1997.

R. Massé, Éthique et santé publique. Enjeux, valeurs et normativité, Québec, Presses de l'université Laval, 2003.

R. Massé, Prévoir et prédire la maladie. Divination et pronostic, Aux Lieux, pp.87-119, 2007.

R. Martinez, What's wrong with me ?": cervical cancer in Venezuela -Living in the borderlands of health, disease, and illness, Social Science and Medicine, vol.61, pp.797-808, 2005.

M. Ménoret, Informer mais convaincre : incertitude médicale et rhéto-rique statistique en cancérologie, Sciences Sociales et Santé, vol.25, pp.33-54, 2007.

A. M. Moulin, Ordre et désordre dans le champ de la santé, Normes et valeurs dans le champ de la santé, pp.19-36, 2004.

J. P. Olivier-de-sardan, La politique du terrain. Sur la production des données en anthropologie, Enquête, vol.1, pp.71-109, 1995.

J. P. Olivier-de-sardan, La rigueur du qualitatif. Les contraintes empiriques de l'interprétation socio-anthropologique, 2008.

I. Pellegrini, A. Sarradon-eck, P. Ben-soussan, A. C. Lacour, R. Largillier et al., Women's perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients' point of view, Psycho-Oncology, vol.19, pp.472-479, 2010.

P. Pinell, Histoire de la lutte contre le cancer en France, 1940.

C. Protière, P. Viens, D. Genre, D. Cowen, J. Camerlo et al., Patient participation in medical decision-making: a french study in adjuvant radio-chemotherapy for early breast cancer, Annals of Oncology, vol.11, pp.39-45, 2000.

G. Rees, A. Fry, and A. Cull, A family history of breast cancer: women's experiences from a theoretical perspective, Social Science and Medicine, vol.52, pp.1433-1440, 2001.

S. Rosman, Cancer and stigma: experience of patients with chemotherapy-induced alopecia, Patient Education and Counseling, vol.52, pp.333-339, 2004.

R. L. Street, Information-giving in medical consultations: the influence of patients' communicative styles and personal characteristics, Social Science and Medicine, vol.32, pp.541-548, 1991.

H. Waizkin, Information giving in medical care, Journal of Health and Social Behavior, vol.26, pp.81-101, 1985.